Agilent Technologies, Inc.: Form 10-Q for the period ended Jan 31, 2022
Filed with the SEC on Mar 3, 2022 and accepted by EDGAR at Mar 3, 2022, 17:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-11-01 to 2022-01-31 | $1.67bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-11-01 to 2022-01-31 | $764.0m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2021-11-01 to 2022-01-31 | $117.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-11-01 to 2022-01-31 | $417.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-11-01 to 2022-01-31 | $376.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-11-01 to 2022-01-31 | $21.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-11-01 to 2022-01-31 | $36.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-11-01 to 2022-01-31 | $283.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-11-01 to 2022-01-31 | $0.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-11-01 to 2022-01-31 | $0.94 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-11-01 to 2022-01-31 | 303,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-11-01 to 2022-01-31 | $255.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-11-01 to 2022-01-31 | $75.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2021-11-01 to 2022-01-31 | $63.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2021-11-01 to 2022-01-31 | $447.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-01-31 | $1.11bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-01-31 | $3.47bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-01-31 | $10.33bn | us-gaap:Assets |
| Current liabilities | At period end2022-01-31 | $1.58bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-01-31 | $5.17bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-01-31 | $2.73bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2022-01-31 | $5.15bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-22-000007. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.